Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Dabigatran and Atorvastatin Interaction
NCT02171039Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2006
- Primary completion
- Aug 2006
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of dabigatran in thromboembolism (3 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the concentration-time curve at steady state at Day 4 and Maximum concentration at steady state at Day 4. Started Jun 2006; status: completed.
02
Drugs
dabigatran
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT02171039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02171039.